Eli Lilly & Company (NYSE: LLY)
DRUGS - Drug Manufacturers - Major
Health Care
Stock price data as of
Closing price: $1025.28
-
Support level$822.48
-
Resistance levelN/A
-
Beta0.7
-
RSI (14-day)89.7
- LLY is at or near its 52-week high. Studies have found that such stocks have an increased probability of outperforming the market over the next year.
- LLY is one of this month's top performers with a return of 27.7 percent, beating 90 percent of stocks in the S&P-100.
- Up 10.9 percent, LLY is one of this week's biggest gainers.
- Volatility is forecast to fall over the next month.
- With RSI > 70, LLY is overbought. Odds slightly favor a short-term price reversal.
- Price broke above prior resistance level - a short-term bullish signal.
| 52-week low | 52-week high | Price as % of range |
|---|---|---|
| $625.65 | $1025.28 | 100.0% |
| 200 day | 50 day | 20 day | 10 day |
|---|---|---|---|
| $798.10 | $827.04 | $892.35 | $961.22 |
Value at risk (VaR)
There is an estimated 5% probability that the stock price will fall by more than VaR in time period.
-
In the next week8.5%
-
In the next month18.2%
-
In the next year78.7%
| Period | Value |
|---|---|
| Historical (5 year) | 32.4% |
| Last month | 33.5% |
| Current estimate | 31.3% |
| Next month forecast | 32.1% |